APO Research
Talk to an analyst

APO RESEARCH · REPORT

Insulin Like Growth Factor 1 Receptor

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Insulin Like Growth Factor 1 Receptor Market Analysis and Forecast 2026-2032

19 December 2025193 pages

Choose your research edition.

Industry ResearchInsulin Like Growth Factor 1 Receptor Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin Like Growth Factor 1 Receptor Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Insulin Like Growth Factor 1 Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin Like Growth Factor 1 Receptor Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin Like Growth Factor 1 Receptor Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Insulin Like Growth Factor 1 Receptor market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Insulin Like Growth Factor 1 Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Insulin Like Growth Factor 1 Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Insulin Like Growth Factor 1 Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Insulin Like Growth Factor 1 Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Insulin Like Growth Factor 1 Receptor include Novartis AG, Merck & Co., Inc., Eli Lilly and Company, AstraZeneca Plc, ProteoThera, Inc., PharmAbcine, Inc., Merrimack Pharmaceuticals, Inc., Insmed Incorporated and Immunomedics, Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Insulin Like Growth Factor 1 Receptor, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Insulin Like Growth Factor 1 Receptor, also provides the sales of main regions and countries. Of the upcoming market potential for Insulin Like Growth Factor 1 Receptor, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Insulin Like Growth Factor 1 Receptor sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Insulin Like Growth Factor 1 Receptor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Insulin Like Growth Factor 1 Receptor sales, projected growth trends, production technology, application and end-user industry.

Insulin Like Growth Factor 1 Receptor Segment by Company

Novartis AG

Merck & Co., Inc.

Eli Lilly and Company

AstraZeneca Plc

ProteoThera, Inc.

PharmAbcine, Inc.

Merrimack Pharmaceuticals, Inc.

Insmed Incorporated

Immunomedics, Inc.

Genmab A/S

F. Hoffmann-La Roche Ltd.

Bristol-Myers Squibb Company

Boehringer Ingelheim GmbH

Axelar AB

Astellas Pharma Inc.

Insulin Like Growth Factor 1 Receptor Segment by Type

CT-707

BI-893923

ATL-1101

1R-E1

Others

Insulin Like Growth Factor 1 Receptor Segment by Application

Hospital

Clinic

Others

Insulin Like Growth Factor 1 Receptor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Like Growth Factor 1 Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin Like Growth Factor 1 Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Like Growth Factor 1 Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Insulin Like Growth Factor 1 Receptor in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Insulin Like Growth Factor 1 Receptor manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Insulin Like Growth Factor 1 Receptor sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Insulin Like Growth Factor 1 Receptor Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. CT-707 Major Manufacturers Table 3. BI-893923 Major Manufacturers Table 4. ATL-1101 Major Manufacturers Table 5. 1R-E1 Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Insulin Like Growth Factor 1 Receptor Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospital Major Manufacturers Table 9. Clinic Major Manufacturers Table 10. Others Major Manufacturers Table 11. Insulin Like Growth Factor 1 Receptor Industry Trends Table 12. Insulin Like Growth Factor 1 Receptor Industry Drivers Table 13. Insulin Like Growth Factor 1 Receptor Industry Opportunities and Challenges Table 14. Insulin Like Growth Factor 1 Receptor Industry Restraints Table 15. Global Insulin Like Growth Factor 1 Receptor Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Insulin Like Growth Factor 1 Receptor Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Insulin Like Growth Factor 1 Receptor Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Region (2021-2026) Table 19. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Region (2027-2032) Table 20. Global Insulin Like Growth Factor 1 Receptor Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 21. Global Insulin Like Growth Factor 1 Receptor Sales by Region (2021-2026) & (W Units) Table 22. Global Insulin Like Growth Factor 1 Receptor Sales by Region (2027-2032) & (W Units) Table 23. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Region (2021-2026) Table 24. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Region (2027-2032) Table 25. Global Insulin Like Growth Factor 1 Receptor Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Insulin Like Growth Factor 1 Receptor Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Manufacturers (2021-2026) Table 29. Global Insulin Like Growth Factor 1 Receptor Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Insulin Like Growth Factor 1 Receptor Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Insulin Like Growth Factor 1 Receptor Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Insulin Like Growth Factor 1 Receptor Manufacturers, Product Type & Application Table 33. Global Insulin Like Growth Factor 1 Receptor Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Insulin Like Growth Factor 1 Receptor by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Insulin Like Growth Factor 1 Receptor Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Insulin Like Growth Factor 1 Receptor Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Insulin Like Growth Factor 1 Receptor Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type (2021-2026) Table 40. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type (2027-2032) Table 41. Global Insulin Like Growth Factor 1 Receptor Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 42. Global Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2026) & (W Units) Table 43. Global Insulin Like Growth Factor 1 Receptor Sales by Type (2027-2032) & (W Units) Table 44. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2021-2026) Table 45. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2027-2032) Table 46. Global Insulin Like Growth Factor 1 Receptor Price by Type (2021-2026) & (US$/Unit) Table 47. Global Insulin Like Growth Factor 1 Receptor Price by Type (2027-2032) & (US$/Unit) Table 48. Global Insulin Like Growth Factor 1 Receptor Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Insulin Like Growth Factor 1 Receptor Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Insulin Like Growth Factor 1 Receptor Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application (2021-2026) Table 52. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application (2027-2032) Table 53. Global Insulin Like Growth Factor 1 Receptor Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 54. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2026) & (W Units) Table 55. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2027-2032) & (W Units) Table 56. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2021-2026) Table 57. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2027-2032) Table 58. Global Insulin Like Growth Factor 1 Receptor Price by Application (2021-2026) & (US$/Unit) Table 59. Global Insulin Like Growth Factor 1 Receptor Price by Application (2027-2032) & (US$/Unit) Table 60. Novartis AG Company Information Table 61. Novartis AG Business Overview Table 62. Novartis AG Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Novartis AG Insulin Like Growth Factor 1 Receptor Product Portfolio Table 64. Novartis AG Recent Development Table 65. Merck & Co., Inc. Company Information Table 66. Merck & Co., Inc. Business Overview Table 67. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 69. Merck & Co., Inc. Recent Development Table 70. Eli Lilly and Company Company Information Table 71. Eli Lilly and Company Business Overview Table 72. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Product Portfolio Table 74. Eli Lilly and Company Recent Development Table 75. AstraZeneca Plc Company Information Table 76. AstraZeneca Plc Business Overview Table 77. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Product Portfolio Table 79. AstraZeneca Plc Recent Development Table 80. ProteoThera, Inc. Company Information Table 81. ProteoThera, Inc. Business Overview Table 82. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 84. ProteoThera, Inc. Recent Development Table 85. PharmAbcine, Inc. Company Information Table 86. PharmAbcine, Inc. Business Overview Table 87. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 89. PharmAbcine, Inc. Recent Development Table 90. Merrimack Pharmaceuticals, Inc. Company Information Table 91. Merrimack Pharmaceuticals, Inc. Business Overview Table 92. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 94. Merrimack Pharmaceuticals, Inc. Recent Development Table 95. Insmed Incorporated Company Information Table 96. Insmed Incorporated Business Overview Table 97. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Product Portfolio Table 99. Insmed Incorporated Recent Development Table 100. Immunomedics, Inc. Company Information Table 101. Immunomedics, Inc. Business Overview Table 102. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 104. Immunomedics, Inc. Recent Development Table 105. Genmab A/S Company Information Table 106. Genmab A/S Business Overview Table 107. Genmab A/S Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Genmab A/S Insulin Like Growth Factor 1 Receptor Product Portfolio Table 109. Genmab A/S Recent Development Table 110. F. Hoffmann-La Roche Ltd. Company Information Table 111. F. Hoffmann-La Roche Ltd. Business Overview Table 112. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 114. F. Hoffmann-La Roche Ltd. Recent Development Table 115. Bristol-Myers Squibb Company Company Information Table 116. Bristol-Myers Squibb Company Business Overview Table 117. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Product Portfolio Table 119. Bristol-Myers Squibb Company Recent Development Table 120. Boehringer Ingelheim GmbH Company Information Table 121. Boehringer Ingelheim GmbH Business Overview Table 122. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Product Portfolio Table 124. Boehringer Ingelheim GmbH Recent Development Table 125. Axelar AB Company Information Table 126. Axelar AB Business Overview Table 127. Axelar AB Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Axelar AB Insulin Like Growth Factor 1 Receptor Product Portfolio Table 129. Axelar AB Recent Development Table 130. Astellas Pharma Inc. Company Information Table 131. Astellas Pharma Inc. Business Overview Table 132. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio Table 134. Astellas Pharma Inc. Recent Development Table 135. North America Insulin Like Growth Factor 1 Receptor Revenue by Type (2021-2026) & (US$ Million) Table 136. North America Insulin Like Growth Factor 1 Receptor Revenue by Type (2027-2032) & (US$ Million) Table 137. North America Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2026) & (W Units) Table 138. North America Insulin Like Growth Factor 1 Receptor Sales by Type (2027-2032) & (W Units) Table 139. North America Insulin Like Growth Factor 1 Receptor Sales Price by Type (2021-2026) & (US$/Unit) Table 140. North America Insulin Like Growth Factor 1 Receptor Sales Price by Type (2027-2032) & (US$/Unit) Table 141. North America Insulin Like Growth Factor 1 Receptor Revenue by Application (2021-2026) & (US$ Million) Table 142. North America Insulin Like Growth Factor 1 Receptor Revenue by Application (2027-2032) & (US$ Million) Table 143. North America Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2026) & (W Units) Table 144. North America Insulin Like Growth Factor 1 Receptor Sales by Application (2027-2032) & (W Units) Table 145. North America Insulin Like Growth Factor 1 Receptor Sales Price by Application (2021-2026) & (US$/Unit) Table 146. North America Insulin Like Growth Factor 1 Receptor Sales Price by Application (2027-2032) & (US$/Unit) Table 147. North America Insulin Like Growth Factor 1 Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. North America Insulin Like Growth Factor 1 Receptor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. North America Insulin Like Growth Factor 1 Receptor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. North America Insulin Like Growth Factor 1 Receptor Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 151. North America Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026) & (W Units) Table 152. North America Insulin Like Growth Factor 1 Receptor Sales by Country (2027-2032) & (W Units) Table 153. North America Insulin Like Growth Factor 1 Receptor Sales Price by Country (2021-2026) & (US$/Unit) Table 154. North America Insulin Like Growth Factor 1 Receptor Sales Price by Country (2027-2032) & (US$/Unit) Table 155. United States Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 156. Canada Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 157. Europe Insulin Like Growth Factor 1 Receptor Revenue by Type (2021-2026) & (US$ Million) Table 158. Europe Insulin Like Growth Factor 1 Receptor Revenue by Type (2027-2032) & (US$ Million) Table 159. Europe Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2026) & (W Units) Table 160. Europe Insulin Like Growth Factor 1 Receptor Sales by Type (2027-2032) & (W Units) Table 161. Europe Insulin Like Growth Factor 1 Receptor Sales Price by Type (2021-2026) & (US$/Unit) Table 162. Europe Insulin Like Growth Factor 1 Receptor Sales Price by Type (2027-2032) & (US$/Unit) Table 163. Europe Insulin Like Growth Factor 1 Receptor Revenue by Application (2021-2026) & (US$ Million) Table 164. Europe Insulin Like Growth Factor 1 Receptor Revenue by Application (2027-2032) & (US$ Million) Table 165. Europe Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2026) & (W Units) Table 166. Europe Insulin Like Growth Factor 1 Receptor Sales by Application (2027-2032) & (W Units) Table 167. Europe Insulin Like Growth Factor 1 Receptor Sales Price by Application (2021-2026) & (US$/Unit) Table 168. Europe Insulin Like Growth Factor 1 Receptor Sales Price by Application (2027-2032) & (US$/Unit) Table 169. Europe Insulin Like Growth Factor 1 Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Europe Insulin Like Growth Factor 1 Receptor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Europe Insulin Like Growth Factor 1 Receptor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 173. Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026) & (W Units) Table 174. Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2027-2032) & (W Units) Table 175. Europe Insulin Like Growth Factor 1 Receptor Sales Price by Country (2021-2026) & (US$/Unit) Table 176. Europe Insulin Like Growth Factor 1 Receptor Sales Price by Country (2027-2032) & (US$/Unit) Table 177. Germany Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 178. France Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 179. U.K. Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 180. Italy Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 181. Netherlands Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 182. Nordic Countries Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 183. China Insulin Like Growth Factor 1 Receptor Revenue by Type (2021-2026) & (US$ Million) Table 184. China Insulin Like Growth Factor 1 Receptor Revenue by Type (2027-2032) & (US$ Million) Table 185. China Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2026) & (W Units) Table 186. China Insulin Like Growth Factor 1 Receptor Sales by Type (2027-2032) & (W Units) Table 187. China Insulin Like Growth Factor 1 Receptor Sales Price by Type (2021-2026) & (US$/Unit) Table 188. China Insulin Like Growth Factor 1 Receptor Sales Price by Type (2027-2032) & (US$/Unit) Table 189. China Insulin Like Growth Factor 1 Receptor Revenue by Application (2021-2026) & (US$ Million) Table 190. China Insulin Like Growth Factor 1 Receptor Revenue by Application (2027-2032) & (US$ Million) Table 191. China Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2026) & (W Units) Table 192. China Insulin Like Growth Factor 1 Receptor Sales by Application (2027-2032) & (W Units) Table 193. China Insulin Like Growth Factor 1 Receptor Sales Price by Application (2021-2026) & (US$/Unit) Table 194. China Insulin Like Growth Factor 1 Receptor Sales Price by Application (2027-2032) & (US$/Unit) Table 195. Asia Insulin Like Growth Factor 1 Receptor Revenue by Type (2021-2026) & (US$ Million) Table 196. Asia Insulin Like Growth Factor 1 Receptor Revenue by Type (2027-2032) & (US$ Million) Table 197. Asia Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2026) & (W Units) Table 198. Asia Insulin Like Growth Factor 1 Receptor Sales by Type (2027-2032) & (W Units) Table 199. Asia Insulin Like Growth Factor 1 Receptor Sales Price by Type (2021-2026) & (US$/Unit) Table 200. Asia Insulin Like Growth Factor 1 Receptor Sales Price by Type (2027-2032) & (US$/Unit) Table 201. Asia Insulin Like Growth Factor 1 Receptor Revenue by Application (2021-2026) & (US$ Million) Table 202. Asia Insulin Like Growth Factor 1 Receptor Revenue by Application (2027-2032) & (US$ Million) Table 203. Asia Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2026) & (W Units) Table 204. Asia Insulin Like Growth Factor 1 Receptor Sales by Application (2027-2032) & (W Units) Table 205. Asia Insulin Like Growth Factor 1 Receptor Sales Price by Application (2021-2026) & (US$/Unit) Table 206. Asia Insulin Like Growth Factor 1 Receptor Sales Price by Application (2027-2032) & (US$/Unit) Table 207. Asia Insulin Like Growth Factor 1 Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 208. Asia Insulin Like Growth Factor 1 Receptor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 209. Asia Insulin Like Growth Factor 1 Receptor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 210. Asia Insulin Like Growth Factor 1 Receptor Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 211. Asia Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026) & (W Units) Table 212. Asia Insulin Like Growth Factor 1 Receptor Sales by Country (2027-2032) & (W Units) Table 213. Asia Insulin Like Growth Factor 1 Receptor Sales Price by Country (2021-2026) & (US$/Unit) Table 214. Asia Insulin Like Growth Factor 1 Receptor Sales Price by Country (2027-2032) & (US$/Unit) Table 215. Japan Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 216. South Korea Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 217. India Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 218. Australia Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 219. China Taiwan Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 220. Southeast Asia Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 221. SAMEA Insulin Like Growth Factor 1 Receptor Revenue by Type (2021-2026) & (US$ Million) Table 222. SAMEA Insulin Like Growth Factor 1 Receptor Revenue by Type (2027-2032) & (US$ Million) Table 223. SAMEA Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2026) & (W Units) Table 224. SAMEA Insulin Like Growth Factor 1 Receptor Sales by Type (2027-2032) & (W Units) Table 225. SAMEA Insulin Like Growth Factor 1 Receptor Sales Price by Type (2021-2026) & (US$/Unit) Table 226. SAMEA Insulin Like Growth Factor 1 Receptor Sales Price by Type (2027-2032) & (US$/Unit) Table 227. SAMEA Insulin Like Growth Factor 1 Receptor Revenue by Application (2021-2026) & (US$ Million) Table 228. SAMEA Insulin Like Growth Factor 1 Receptor Revenue by Application (2027-2032) & (US$ Million) Table 229. SAMEA Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2026) & (W Units) Table 230. SAMEA Insulin Like Growth Factor 1 Receptor Sales by Application (2027-2032) & (W Units) Table 231. SAMEA Insulin Like Growth Factor 1 Receptor Sales Price by Application (2021-2026) & (US$/Unit) Table 232. SAMEA Insulin Like Growth Factor 1 Receptor Sales Price by Application (2027-2032) & (US$/Unit) Table 233. SAMEA Insulin Like Growth Factor 1 Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 234. SAMEA Insulin Like Growth Factor 1 Receptor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 235. SAMEA Insulin Like Growth Factor 1 Receptor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 236. SAMEA Insulin Like Growth Factor 1 Receptor Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 237. SAMEA Insulin Like Growth Factor 1 Receptor Sales by Country (2021-2026) & (W Units) Table 238. SAMEA Insulin Like Growth Factor 1 Receptor Sales by Country (2027-2032) & (W Units) Table 239. SAMEA Insulin Like Growth Factor 1 Receptor Sales Price by Country (2021-2026) & (US$/Unit) Table 240. SAMEA Insulin Like Growth Factor 1 Receptor Sales Price by Country (2027-2032) & (US$/Unit) Table 241. Brazil Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 242. Argentina Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 243. Chile Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 244. Colombia Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 245. Peru Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 246. Saudi Arabia Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 247. Israel Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 248. UAE Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 249. Turkey Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 250. Iran Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 251. Egypt Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Table 252. Key Raw Materials Table 253. Raw Materials Key Suppliers Table 254. Insulin Like Growth Factor 1 Receptor Distributors List Table 255. Insulin Like Growth Factor 1 Receptor Customers List Table 256. Research Programs/Design for This Report Table 257. Authors List of This Report Table 258. Secondary Sources Table 259. Primary Sources List of Figures Figure 1. Insulin Like Growth Factor 1 Receptor Image Figure 2. Global Insulin Like Growth Factor 1 Receptor Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin Like Growth Factor 1 Receptor Market Size Share 2021 VS 2025 VS 2032 Figure 4. CT-707 Image Figure 5. BI-893923 Image Figure 6. ATL-1101 Image Figure 7. 1R-E1 Image Figure 8. Others Image Figure 9. Global Insulin Like Growth Factor 1 Receptor Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Insulin Like Growth Factor 1 Receptor Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospital Image Figure 12. Clinic Image Figure 13. Others Image Figure 14. Global Insulin Like Growth Factor 1 Receptor Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Insulin Like Growth Factor 1 Receptor Revenue (2021-2032) & (US$ Million) Figure 16. Global Insulin Like Growth Factor 1 Receptor Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Region (2021-2032) Figure 19. Global Insulin Like Growth Factor 1 Receptor Sales (2021-2032) & (W Units) Figure 20. Global Insulin Like Growth Factor 1 Receptor Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 21. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Insulin Like Growth Factor 1 Receptor Sales YoY (2021-2032) & (W Units) Figure 23. Europe Insulin Like Growth Factor 1 Receptor Sales YoY (2021-2032) & (W Units) Figure 24. China Insulin Like Growth Factor 1 Receptor Sales YoY (2021-2032) & (W Units) Figure 25. Asia (Excluding China) Insulin Like Growth Factor 1 Receptor Sales YoY (2021-2032) & (W Units) Figure 26. South America, Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales YoY (2021-2032) & (W Units) Figure 27. Global Insulin Like Growth Factor 1 Receptor Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Insulin Like Growth Factor 1 Receptor Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Insulin Like Growth Factor 1 Receptor Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type (2021-2032) Figure 33. Global Insulin Like Growth Factor 1 Receptor Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 34. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2021-2032) Figure 36. Global Insulin Like Growth Factor 1 Receptor Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application (2021-2032) Figure 39. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 40. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2021-2032) Figure 42. North America Insulin Like Growth Factor 1 Receptor Revenue Share by Type (2021-2032) Figure 43. North America Insulin Like Growth Factor 1 Receptor Sales Share by Type (2021-2032) Figure 44. North America Insulin Like Growth Factor 1 Receptor Revenue Share by Application (2021-2032) Figure 45. North America Insulin Like Growth Factor 1 Receptor Sales Share by Application (2021-2032) Figure 46. North America Insulin Like Growth Factor 1 Receptor Revenue Share by Country (2021-2032) Figure 47. North America Insulin Like Growth Factor 1 Receptor Sales Share by Country (2021-2032) Figure 48. Europe Insulin Like Growth Factor 1 Receptor Revenue Share by Type (2021-2032) Figure 49. Europe Insulin Like Growth Factor 1 Receptor Sales Share by Type (2021-2032) Figure 50. Europe Insulin Like Growth Factor 1 Receptor Revenue Share by Application (2021-2032) Figure 51. Europe Insulin Like Growth Factor 1 Receptor Sales Share by Application (2021-2032) Figure 52. Europe Insulin Like Growth Factor 1 Receptor Revenue Share by Country (2021-2032) Figure 53. Europe Insulin Like Growth Factor 1 Receptor Sales Share by Country (2021-2032) Figure 54. China Insulin Like Growth Factor 1 Receptor Revenue Share by Type (2021-2032) Figure 55. China Insulin Like Growth Factor 1 Receptor Sales Share by Type (2021-2032) Figure 56. China Insulin Like Growth Factor 1 Receptor Revenue Share by Application (2021-2032) Figure 57. China Insulin Like Growth Factor 1 Receptor Sales Share by Application (2021-2032) Figure 58. Asia Insulin Like Growth Factor 1 Receptor Revenue Share by Type (2021-2032) Figure 59. Asia Insulin Like Growth Factor 1 Receptor Sales Share by Type (2021-2032) Figure 60. Asia Insulin Like Growth Factor 1 Receptor Revenue Share by Application (2021-2032) Figure 61. Asia Insulin Like Growth Factor 1 Receptor Sales Share by Application (2021-2032) Figure 62. Asia Insulin Like Growth Factor 1 Receptor Revenue Share by Country (2021-2032) Figure 63. Asia Insulin Like Growth Factor 1 Receptor Sales Share by Country (2021-2032) Figure 64. SAMEA Insulin Like Growth Factor 1 Receptor Revenue Share by Type (2021-2032) Figure 65. SAMEA Insulin Like Growth Factor 1 Receptor Sales Share by Type (2021-2032) Figure 66. SAMEA Insulin Like Growth Factor 1 Receptor Revenue Share by Application (2021-2032) Figure 67. SAMEA Insulin Like Growth Factor 1 Receptor Sales Share by Application (2021-2032) Figure 68. SAMEA Insulin Like Growth Factor 1 Receptor Revenue Share by Country (2021-2032) Figure 69. SAMEA Insulin Like Growth Factor 1 Receptor Sales Share by Country (2021-2032) Figure 70. Insulin Like Growth Factor 1 Receptor Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Insulin Like Growth Factor 1 Receptor Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • CT-707
  • BI-893923
  • ATL-1101
  • 1R-E1
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Novartis AG
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • AstraZeneca Plc
  • ProteoThera, Inc.
  • PharmAbcine, Inc.
  • Merrimack Pharmaceuticals, Inc.
  • Insmed Incorporated
  • Immunomedics, Inc.
  • Genmab A/S
  • F. Hoffmann-La Roche Ltd.
  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim GmbH
  • Axelar AB
  • Astellas Pharma Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Insulin Like Growth Factor 1 Receptor Market by Type
  3. 1.2.1 Global Insulin Like Growth Factor 1 Receptor Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 CT-707
  5. 1.2.3 BI-893923
  6. 1.2.4 ATL-1101
  7. 1.2.5 1R-E1
  8. 1.2.6 Others
  9. 1.3 Insulin Like Growth Factor 1 Receptor Market by Application
  10. 1.3.1 Global Insulin Like Growth Factor 1 Receptor Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Clinic
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Insulin Like Growth Factor 1 Receptor Market Dynamics
  1. 2.1 Insulin Like Growth Factor 1 Receptor Industry Trends
  2. 2.2 Insulin Like Growth Factor 1 Receptor Industry Drivers
  3. 2.3 Insulin Like Growth Factor 1 Receptor Industry Opportunities and Challenges
  4. 2.4 Insulin Like Growth Factor 1 Receptor Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Insulin Like Growth Factor 1 Receptor Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Region
  3. 3.2.1 Global Insulin Like Growth Factor 1 Receptor Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Region (2021-2026)
  5. 3.2.3 Global Insulin Like Growth Factor 1 Receptor Revenue by Region (2027-2032)
  6. 3.2.4 Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Insulin Like Growth Factor 1 Receptor Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Insulin Like Growth Factor 1 Receptor Sales by Region
  9. 3.4.1 Global Insulin Like Growth Factor 1 Receptor Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Insulin Like Growth Factor 1 Receptor Sales by Region (2021-2026)
  11. 3.4.3 Global Insulin Like Growth Factor 1 Receptor Sales by Region (2027-2032)
  12. 3.4.4 Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Insulin Like Growth Factor 1 Receptor Revenue by Manufacturers
  2. 4.1.1 Global Insulin Like Growth Factor 1 Receptor Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Insulin Like Growth Factor 1 Receptor Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Insulin Like Growth Factor 1 Receptor Sales by Manufacturers
  6. 4.2.1 Global Insulin Like Growth Factor 1 Receptor Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Insulin Like Growth Factor 1 Receptor Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Insulin Like Growth Factor 1 Receptor Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Insulin Like Growth Factor 1 Receptor Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Insulin Like Growth Factor 1 Receptor Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Insulin Like Growth Factor 1 Receptor Manufacturers, Product Type & Application
  13. 4.7 Global Insulin Like Growth Factor 1 Receptor Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Insulin Like Growth Factor 1 Receptor Market CR5 and HHI
  16. 4.8.2 2025 Insulin Like Growth Factor 1 Receptor Tier 1, Tier 2, and Tier 3
5 Insulin Like Growth Factor 1 Receptor Market by Type
  1. 5.1 Global Insulin Like Growth Factor 1 Receptor Revenue by Type
  2. 5.1.1 Global Insulin Like Growth Factor 1 Receptor Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Insulin Like Growth Factor 1 Receptor Sales by Type
  6. 5.2.1 Global Insulin Like Growth Factor 1 Receptor Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2021-2032)
  9. 5.3 Global Insulin Like Growth Factor 1 Receptor Price by Type
6 Insulin Like Growth Factor 1 Receptor Market by Application
  1. 6.1 Global Insulin Like Growth Factor 1 Receptor Revenue by Application
  2. 6.1.1 Global Insulin Like Growth Factor 1 Receptor Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Insulin Like Growth Factor 1 Receptor Sales by Application
  6. 6.2.1 Global Insulin Like Growth Factor 1 Receptor Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2021-2032)
  9. 6.3 Global Insulin Like Growth Factor 1 Receptor Price by Application
7 Company Profiles
  1. 7.1 Novartis AG
  2. 7.1.1 Novartis AG Company Information
  3. 7.1.2 Novartis AG Business Overview
  4. 7.1.3 Novartis AG Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis AG Insulin Like Growth Factor 1 Receptor Product Portfolio
  6. 7.1.5 Novartis AG Recent Developments
  7. 7.2 Merck & Co., Inc.
  8. 7.2.1 Merck & Co., Inc. Company Information
  9. 7.2.2 Merck & Co., Inc. Business Overview
  10. 7.2.3 Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  12. 7.2.5 Merck & Co., Inc. Recent Developments
  13. 7.3 Eli Lilly and Company
  14. 7.3.1 Eli Lilly and Company Company Information
  15. 7.3.2 Eli Lilly and Company Business Overview
  16. 7.3.3 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Product Portfolio
  18. 7.3.5 Eli Lilly and Company Recent Developments
  19. 7.4 AstraZeneca Plc
  20. 7.4.1 AstraZeneca Plc Company Information
  21. 7.4.2 AstraZeneca Plc Business Overview
  22. 7.4.3 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Product Portfolio
  24. 7.4.5 AstraZeneca Plc Recent Developments
  25. 7.5 ProteoThera, Inc.
  26. 7.5.1 ProteoThera, Inc. Company Information
  27. 7.5.2 ProteoThera, Inc. Business Overview
  28. 7.5.3 ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  30. 7.5.5 ProteoThera, Inc. Recent Developments
  31. 7.6 PharmAbcine, Inc.
  32. 7.6.1 PharmAbcine, Inc. Company Information
  33. 7.6.2 PharmAbcine, Inc. Business Overview
  34. 7.6.3 PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  36. 7.6.5 PharmAbcine, Inc. Recent Developments
  37. 7.7 Merrimack Pharmaceuticals, Inc.
  38. 7.7.1 Merrimack Pharmaceuticals, Inc. Company Information
  39. 7.7.2 Merrimack Pharmaceuticals, Inc. Business Overview
  40. 7.7.3 Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  42. 7.7.5 Merrimack Pharmaceuticals, Inc. Recent Developments
  43. 7.8 Insmed Incorporated
  44. 7.8.1 Insmed Incorporated Company Information
  45. 7.8.2 Insmed Incorporated Business Overview
  46. 7.8.3 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Product Portfolio
  48. 7.8.5 Insmed Incorporated Recent Developments
  49. 7.9 Immunomedics, Inc.
  50. 7.9.1 Immunomedics, Inc. Company Information
  51. 7.9.2 Immunomedics, Inc. Business Overview
  52. 7.9.3 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  54. 7.9.5 Immunomedics, Inc. Recent Developments
  55. 7.10 Genmab A/S
  56. 7.10.1 Genmab A/S Company Information
  57. 7.10.2 Genmab A/S Business Overview
  58. 7.10.3 Genmab A/S Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Genmab A/S Insulin Like Growth Factor 1 Receptor Product Portfolio
  60. 7.10.5 Genmab A/S Recent Developments
  61. 7.11 F. Hoffmann-La Roche Ltd.
  62. 7.11.1 F. Hoffmann-La Roche Ltd. Company Information
  63. 7.11.2 F. Hoffmann-La Roche Ltd. Business Overview
  64. 7.11.3 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Product Portfolio
  66. 7.11.5 F. Hoffmann-La Roche Ltd. Recent Developments
  67. 7.12 Bristol-Myers Squibb Company
  68. 7.12.1 Bristol-Myers Squibb Company Company Information
  69. 7.12.2 Bristol-Myers Squibb Company Business Overview
  70. 7.12.3 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Product Portfolio
  72. 7.12.5 Bristol-Myers Squibb Company Recent Developments
  73. 7.13 Boehringer Ingelheim GmbH
  74. 7.13.1 Boehringer Ingelheim GmbH Company Information
  75. 7.13.2 Boehringer Ingelheim GmbH Business Overview
  76. 7.13.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Product Portfolio
  78. 7.13.5 Boehringer Ingelheim GmbH Recent Developments
  79. 7.14 Axelar AB
  80. 7.14.1 Axelar AB Company Information
  81. 7.14.2 Axelar AB Business Overview
  82. 7.14.3 Axelar AB Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Axelar AB Insulin Like Growth Factor 1 Receptor Product Portfolio
  84. 7.14.5 Axelar AB Recent Developments
  85. 7.15 Astellas Pharma Inc.
  86. 7.15.1 Astellas Pharma Inc. Company Information
  87. 7.15.2 Astellas Pharma Inc. Business Overview
  88. 7.15.3 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Product Portfolio
  90. 7.15.5 Astellas Pharma Inc. Recent Developments
8 North America
  1. 8.1 North America Insulin Like Growth Factor 1 Receptor Market Size by Type
  2. 8.1.1 North America Insulin Like Growth Factor 1 Receptor Revenue by Type (2021-2032)
  3. 8.1.2 North America Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2032)
  4. 8.1.3 North America Insulin Like Growth Factor 1 Receptor Price by Type (2021-2032)
  5. 8.2 North America Insulin Like Growth Factor 1 Receptor Market Size by Application
  6. 8.2.1 North America Insulin Like Growth Factor 1 Receptor Revenue by Application (2021-2032)
  7. 8.2.2 North America Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2032)
  8. 8.2.3 North America Insulin Like Growth Factor 1 Receptor Price by Application (2021-2032)
  9. 8.3 North America Insulin Like Growth Factor 1 Receptor Market Size by Country
  10. 8.3.1 North America Insulin Like Growth Factor 1 Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Insulin Like Growth Factor 1 Receptor Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Insulin Like Growth Factor 1 Receptor Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Insulin Like Growth Factor 1 Receptor Market Size by Type
  2. 9.1.1 Europe Insulin Like Growth Factor 1 Receptor Revenue by Type (2021-2032)
  3. 9.1.2 Europe Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2032)
  4. 9.1.3 Europe Insulin Like Growth Factor 1 Receptor Price by Type (2021-2032)
  5. 9.2 Europe Insulin Like Growth Factor 1 Receptor Market Size by Application
  6. 9.2.1 Europe Insulin Like Growth Factor 1 Receptor Revenue by Application (2021-2032)
  7. 9.2.2 Europe Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2032)
  8. 9.2.3 Europe Insulin Like Growth Factor 1 Receptor Price by Application (2021-2032)
  9. 9.3 Europe Insulin Like Growth Factor 1 Receptor Market Size by Country
  10. 9.3.1 Europe Insulin Like Growth Factor 1 Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Insulin Like Growth Factor 1 Receptor Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Insulin Like Growth Factor 1 Receptor Market Size by Type
  2. 10.1.1 China Insulin Like Growth Factor 1 Receptor Revenue by Type (2021-2032)
  3. 10.1.2 China Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2032)
  4. 10.1.3 China Insulin Like Growth Factor 1 Receptor Price by Type (2021-2032)
  5. 10.2 China Insulin Like Growth Factor 1 Receptor Market Size by Application
  6. 10.2.1 China Insulin Like Growth Factor 1 Receptor Revenue by Application (2021-2032)
  7. 10.2.2 China Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2032)
  8. 10.2.3 China Insulin Like Growth Factor 1 Receptor Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Insulin Like Growth Factor 1 Receptor Market Size by Type
  2. 11.1.1 Asia Insulin Like Growth Factor 1 Receptor Revenue by Type (2021-2032)
  3. 11.1.2 Asia Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2032)
  4. 11.1.3 Asia Insulin Like Growth Factor 1 Receptor Price by Type (2021-2032)
  5. 11.2 Asia Insulin Like Growth Factor 1 Receptor Market Size by Application
  6. 11.2.1 Asia Insulin Like Growth Factor 1 Receptor Revenue by Application (2021-2032)
  7. 11.2.2 Asia Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2032)
  8. 11.2.3 Asia Insulin Like Growth Factor 1 Receptor Price by Application (2021-2032)
  9. 11.3 Asia Insulin Like Growth Factor 1 Receptor Market Size by Country
  10. 11.3.1 Asia Insulin Like Growth Factor 1 Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Insulin Like Growth Factor 1 Receptor Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Insulin Like Growth Factor 1 Receptor Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Insulin Like Growth Factor 1 Receptor Market Size by Type
  2. 12.1.1 SAMEA Insulin Like Growth Factor 1 Receptor Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Insulin Like Growth Factor 1 Receptor Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Insulin Like Growth Factor 1 Receptor Price by Type (2021-2032)
  5. 12.2 SAMEA Insulin Like Growth Factor 1 Receptor Market Size by Application
  6. 12.2.1 SAMEA Insulin Like Growth Factor 1 Receptor Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Insulin Like Growth Factor 1 Receptor Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Insulin Like Growth Factor 1 Receptor Price by Application (2021-2032)
  9. 12.3 SAMEA Insulin Like Growth Factor 1 Receptor Market Size by Country
  10. 12.3.1 SAMEA Insulin Like Growth Factor 1 Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Insulin Like Growth Factor 1 Receptor Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Insulin Like Growth Factor 1 Receptor Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Insulin Like Growth Factor 1 Receptor Value Chain Analysis
  2. 13.1.1 Insulin Like Growth Factor 1 Receptor Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Insulin Like Growth Factor 1 Receptor Production Mode & Process
  6. 13.2 Insulin Like Growth Factor 1 Receptor Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Insulin Like Growth Factor 1 Receptor Distributors
  9. 13.2.3 Insulin Like Growth Factor 1 Receptor Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst